Orsolya Biro
Overview
Explore the profile of Orsolya Biro including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
15
Citations
319
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Biro O, Alasztics B, Molvarec A, Joo J, Nagy B, Rigo Jr J
Pregnancy Hypertens
. 2017 Nov;
10:207-212.
PMID: 29153681
Introduction: Hypertension is a common complication during pregnancy, affecting 10% of pregnant women worldwide. Several microRNA (miRNA) were shown to be involved in hypertensive disorders of pregnancy. In preeclampsia (PE),...
12.
Chandrasekaran A, Avci H, Ochalek A, Rosingh L, Molnar K, Laszlo L, et al.
Stem Cell Res
. 2017 Nov;
25:139-151.
PMID: 29128818
Neural progenitor cells (NPCs) from human induced pluripotent stem cells (hiPSCs) are frequently induced using 3D culture methodologies however, it is unknown whether spheroid-based (3D) neural induction is actually superior...
13.
Biro O, Nagy B, Rigo Jr J
Hypertens Pregnancy
. 2016 Nov;
36(1):90-99.
PMID: 27835046
Background: Preeclampsia (PE) is the major cause of maternal and fetal morbidity and mortality, affecting 3-8% of all pregnancies around the globe. miRNAs are small, noncoding RNA molecules, which negatively...
14.
Minarik G, Repiska G, Hyblova M, Nagyova E, Soltys K, Budis J, et al.
PLoS One
. 2015 Dec;
10(12):e0144811.
PMID: 26669558
Objectives: The aims of this study were to test the utility of benchtop NGS platforms for NIPT for trisomy 21 using previously published z score calculation methods and to optimize...
15.
Kehler L, Biro O, Lazar L, Rigo Jr J, Nagy B
Biomed Rep
. 2015 Dec;
3(6):869-873.
PMID: 26623032
The current standard for prenatal screening is mostly based on biochemical marker tests and the use of ultrasonography. There is no secure stand-alone screening marker for congenital heart defects (CHDs)....